HAS Grants Reimbursement to Theraclion

The French’s National Health Authority has given a favorable opinion for reimbursement to Theraclion’s Echopulse for the treatment of non-malignant breast tumors.

The two main objectives of this system are to accelerate patient access to medical innovations and support business development.

The study has been approved to commence in 12 hospitals across France. — Cynthia Jessup